| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 10/15/2002 | US6465509 Pyrones as inhibitors of cyclooxygenase-2 |
| 10/15/2002 | CA2112690C Amino acid derivative |
| 10/10/2002 | WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/10/2002 | WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/10/2002 | WO2002057251A3 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 10/10/2002 | US20020147351 Lactonization process |
| 10/10/2002 | US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
| 10/10/2002 | US20020146588 Novel compound for red organic electroluminescent elements and devices |
| 10/10/2002 | CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/09/2002 | EP1247807A1 Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyran compound |
| 10/09/2002 | EP1246626A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance |
| 10/09/2002 | CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds |
| 10/09/2002 | CN1373660A Method for treating chronic pain using MEK inhibitors |
| 10/08/2002 | US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 10/08/2002 | US6461838 Polyketides |
| 10/08/2002 | CA2216245C Preparation of cis-4-o-protected-2-cyclopentenol derivatives |
| 10/03/2002 | WO2002076980A1 Sialic acid derivatives |
| 10/03/2002 | WO2002076971A1 Compounds useful for inhibiting paramyxovirus neuraminidase |
| 10/03/2002 | WO2002076402A2 Fatty amine drug conjugates |
| 10/03/2002 | WO2001029020A9 Neuraminidase inhibitors |
| 10/02/2002 | EP1245553A2 Palladium-catalysed synthesis of aryl ethers |
| 10/02/2002 | CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection |
| 10/01/2002 | US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives |
| 10/01/2002 | US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia. |
| 10/01/2002 | US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto |
| 09/26/2002 | WO2002046507A3 Onium salts and the use therof as latent acids |
| 09/26/2002 | US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma |
| 09/26/2002 | US20020137903 Sodium dependent glucose transporters found in the intestine and kidney (SGLT2); treating diabetes |
| 09/26/2002 | US20020137791 Sialidase inhibitors; influenza viricides |
| 09/26/2002 | US20020137789 Anticancer agents |
| 09/25/2002 | EP1242437A2 Novel stromelysin inhibitors |
| 09/25/2002 | EP1242379A1 Curcumin analogues for treating cancer |
| 09/25/2002 | CN1371362A Process for preparation of isotretinoin |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/24/2002 | US6455707 Forming 2-ethynyl-tetrahydro-2,6,6-trialkylpyran by exposing dehydrolinalool or higher homologues to microwave irradiation using a solid acid catalyst such as a zeolite |
| 09/19/2002 | WO2002072566A1 A lactonization process |
| 09/19/2002 | WO2002024194A9 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 09/19/2002 | US20020133030 Processes for preparing 3-arylsulfur hydroxamic acids |
| 09/19/2002 | US20020133017 Chromatographic separation of enantiomers of lactones |
| 09/19/2002 | US20020130300 For use in liquid-crystal and electro-optical display elements |
| 09/19/2002 | DE10111065A1 Verbessertes Verfahren zur Herstellung von ungesättigten cyclischen Ethern An improved process for preparing unsaturated cyclic ethers |
| 09/18/2002 | EP1241164A1 Process for preparation of tetrahydropyranyloxyamines |
| 09/18/2002 | EP0891962B1 Process for the preparation of fluorinated dicarbonyl compounds |
| 09/18/2002 | EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451766 Sialidase inhibitors; influenza viricides |
| 09/17/2002 | US6451456 Compound for red organic EL device and organic EL device using the same |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070128A1 Improved method for producing unsaturated cyclic ethers |
| 09/12/2002 | US20020128434 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/12/2002 | US20020128250 Modulating the expression of a gene |
| 09/12/2002 | US20020128214 C-glucosyl ether lipids |
| 09/12/2002 | US20020127428 Organic light emitting displays and new fluorescent compounds |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/11/2002 | EP1237914A1 Methods for improving secondary metabolite production in fungi |
| 09/11/2002 | EP0958287B1 Sulfamide-metalloprotease inhibitors |
| 09/11/2002 | EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 09/11/2002 | CN1368984A Synthesis of copolymers containing anhydrofructose derivatives |
| 09/10/2002 | USRE37839 Fungicides, insecticides, miticides, nematocides, and pesticides |
| 09/10/2002 | US6448415 Reacting lactone compound with secondary amine and sulfonyl group containing compound (methanesulfonylchloride); for preparing l-ribose |
| 09/10/2002 | US6448273 Such as 2,6-dimethoxymethyl-1-methyl-3-benzyloxpyridin-4(1h)-one; treating disorders associated with iron distribution and iron dependant parasites; reduced levels of active agent; selective targeting to tissues and liver; metabolic stability |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/06/2002 | WO2002068404A1 Method for producing optically active dihydropyrones |
| 09/06/2002 | WO2002068403A1 Continuous method for producing dihydropyrones |
| 09/06/2002 | WO2002053094A3 Method for detoxifying a carbohydrate containing solution |
| 09/06/2002 | WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides |
| 09/05/2002 | DE10108470A1 Verfahren zur Herstellung optisch aktiver Dihydropyrone A process for preparing optically active dihydropyrones |
| 09/04/2002 | EP1236714A1 Acetalsulfonate derivative, process for producing the same, and process for producing styrene oxide derivative |
| 09/04/2002 | EP1235821A2 Pyrone derivatives and a method for producing same |
| 09/04/2002 | EP1235820A2 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 09/04/2002 | EP1087958B1 Process to manufacture simvastatin and intermediates |
| 09/04/2002 | CN1367777A Benzenamine derivatives as anti-coagulants |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444452 Process for recovering statin compounds from a fermentation broth |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | WO2002015894A3 Use of vitamin d derivatives as bone resorption inhibitors |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | US20020120168 Difluoromethyl ether derivative and process for producing the same |
| 08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/28/2002 | EP1234884A1 A process for the preparation of beta-hydroxy-delta-lactone using novel intermediates |
| 08/28/2002 | EP1233956A1 Bryostatin analogues, synthetic methods and uses |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/27/2002 | US6441243 Forming ketones, aldehydes |
| 08/27/2002 | US6441237 Drugs; antiarrhthymia agents, antiischemic agents |
| 08/27/2002 | US6441226 Process for the preparation of isotretinoin |
| 08/27/2002 | US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity |
| 08/27/2002 | US6441030 3-phenyl-pyrones |
| 08/27/2002 | US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 08/22/2002 | WO2002064587A1 Ratjadone derivatives for inhibiting cell growth |
| 08/22/2002 | WO2002064550A1 Glucocorticoid receptor modulators |
| 08/22/2002 | US20020115712 Highly purified simvastatin compositions |
| 08/22/2002 | US20020115079 Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis |
| 08/22/2002 | DE10106647A1 Ratjadon-Derivate zum Hemmen des Zellwachstums Ratjadone derivatives for inhibiting cell growth |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1231984A1 Phorboxazole derivatives for treating cancer |